¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) Á¦ 36ȸ ¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö°­Á : 2021-09-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) Á¦ 36ȸ ¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö°­Á : 2021-09-26
±³À°ÀÏÀÚ : 2021-09-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦ 36ȸ ¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°ú  
´ã´çÀÚ : °íÈñº´
¿¬¶ôó : 02-2228-1932  
À̸ÞÀÏ : kjcvkjcv@gmail.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í 40,000¿ø (ÀϹÝÀÇ, Àü¹®ÀÇ) 30,000¿ø (Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-26 ¿Â¶óÀΠ08:50~09:00 °³È¸»ç  ±è¹ü¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ09:00~09:35 Practical consideration for anemia management in dialysis patients  ÃÖÈÆ¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ09:35~10:10 Intradialytic hypotension : From mechanism to strategies  ±èÇü¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ10:10~10:45 Preparation of transplantation in dialysis patients and dialysis care after graft failure  ¾çÀç¼®(¼­¿ïÀÇ´ë) 
È޽Ġ09-26  10:45~11:00 Coffee break  () 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ11:00~11:35 Updated KDIGO DM guideline 2020  ÀÌÁ¤Àº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ11:35~12:10 Updated KDIGO HTN guideline 2021  ÁÖ¿µ¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ12:10~12:45 SGLT2 inhibitor use in CKD patients  ¹ÚÁ¤Å¹(¿¬¼¼ÀÇ´ë) 
½Ä»ç 09-26  12:45~13:30 Lunch  () 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ13:30~14:05 ESRD patients and COVID-19: From infection to prevention  ¾ÈÁø¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ14:05~14:40 Management of osteoporosis in CKD  È«³²±â(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-26 ¿Â¶óÀΠ14:40~15:15 How to deal with complication of vascular access for hemodialysis: Surgeon  Çã¼±Èñ(¿¬¼¼ÀÇ´ë) 
±âŸ 09-26 ¿Â¶óÀΠ15:15~15:30 Æóȸ»ç  ±è¹ü¼®(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) Á¦ 36ȸ ¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö°­Á : 2021-09-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021 Á¦ 22ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¾ö : 2021-09-26
´ÙÀ½±Û ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ (¿Â¶óÀÎ) Á¦58Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2021-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20424 ¼­¿ï ´ëÇÑ»óºÎÀ§Àå°ü¡¤Ç︮ÄÚ¹ÚÅÍÇÐȸ Á¦ 30Â÷ ÇмúÁý´ãȸ : 2024-04-29 0 46 2024-04-16
20423 °æ±â (¿Â¶óÀÎ) 2024³â 1Â÷ ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Áý´ãȸ : 2024-04-29 0 82 2024-04-16
20422 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°¡¿Í»ç³¢º´ÇÐȸ Çмú´ëȸ (Á¦18ȸ °¡¿Í»ç³¢º´ ½ÉÆ÷Áö¿ò) : 2024-04-28 0 62 2024-04-16
20421 ¼­¿ï 2024³âµµ ´ëÇѽŰæ°úÇÐȸ ÅëÁõ ½Ç±â ¿öÅ©¼ó : 2024-04-28 0 59 2024-04-16
20420 ¼­¿ï ½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (2ÀÏÂ÷) : 2024-04-27 0 60 2024-04-16
20419 ¼­¿ï ´ëÇѺñ´¢»ý½Ä¿µ»óÀÇÇÐȸ Á¦21ȸ Á¤±âÇмú´ëȸ : 2024-04-27 0 47 2024-04-16
20418 ±¤ÁÖ ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_3rd day : 2024-04-27 0 41 2024-04-16
20417 ºÎ»ê ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(2ÀÏÂ÷) : 2024-04-27 0 48 2024-04-16
20416 ¼­¿ï 2024³â ´ëÇѳ»°úÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-27 0 58 2024-04-16
20415 ºÎ»ê 2024 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦39Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-04-27 0 26 2024-04-16
20414 ¼­¿ï 2024 Çѱ¹´ç´¢º´¿¹¹æ¿¬±¸(KDPS) Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-27 0 37 2024-04-16
20413 ¼­¿ï ½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (1ÀÏÂ÷) : 2024-04-26 0 2,830 2024-04-15
20412 ¼­¿ï ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-26 0 2,522 2024-04-15
20411 ±¤ÁÖ ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26 0 2,594 2024-04-15
20410 ºÎ»ê ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2024-04-26 0 2,587 2024-04-15
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷